Leading expert in breast cancer hormone therapy, Dr. Marc Lippman, MD, explains the evolution of endocrine treatment. He is a professor of oncology and medicine at Georgetown University. Dr. Lippman is board certified in endocrinology, metabolism, and medical oncology. His distinguished career includes leadership roles at the NIH, University of Michigan, and University of Miami. Dr. Lippman has published over 400 peer-reviewed articles on breast cancer.
More from Breast Cancer
More from DiagnosticDetectives.Com
Endocrine Therapy for Breast Cancer: Expert Insights on Hormone Treatment
Jump To Section
- Expert Background and Credentials
- Medical Education and Specialized Training
- Distinguished Academic Leadership Career
- Research Contributions and Publications
- Clinical Expertise in Breast Cancer
- Full Transcript
Expert Background and Credentials
Dr. Marc Lippman, MD, is an eminent expert on endocrine treatment for breast cancer. He holds the prestigious position of Professor of Oncology and Medicine at Georgetown University in Washington, DC. Dr. Lippman is a pioneer in the field of hormonal therapy for breast cancer patients.
His dual board certifications in endocrinology and metabolism and medical oncology provide a unique perspective on breast cancer treatment. This combination allows Dr. Lippman to approach breast cancer from both hormonal and oncological viewpoints.
Medical Education and Specialized Training
Dr. Marc Lippman, MD, obtained his medical degree from Yale University, a leading institution in medical education. He completed his residency in internal medicine at Johns Hopkins University, known for its rigorous clinical training programs.
Dr. Lippman pursued advanced fellowship training in endocrinology at both Yale University and the National Institutes of Health (NIH). This comprehensive training provided him with deep expertise in hormonal systems and their relationship to cancer development and treatment.
Distinguished Academic Leadership Career
Dr. Marc Lippman, MD, has held numerous prestigious academic leadership positions throughout his career. He served as Head of the Medical Breast Cancer Section at the NIH, where he focused on advancing breast cancer research. Dr. Lippman was Professor and Chair of Internal Medicine at the University of Michigan, overseeing a major academic department.
His leadership extended to the University of Miami, where he served as Professor of Medicine and Chair of the Medicine Department. Dr. Lippman also held the position of Deputy Director of the Sylvester Comprehensive Cancer Center at the University of Miami. At Georgetown University, he was Professor of Medicine and Pharmacology and Chair of the Department of Oncology.
Research Contributions and Publications
Dr. Marc Lippman, MD, has made substantial research contributions to breast cancer treatment. He has published over 400 articles in peer-reviewed medical journals, focusing primarily on oncology and endocrine aspects of breast cancer. His extensive publication record demonstrates his commitment to advancing medical knowledge.
Dr. Lippman has received numerous national and international awards recognizing his work on endocrine aspects of breast cancer. These honors reflect the significant impact of his research on clinical practice and patient care. Dr. Anton Titov, MD, highlights Dr. Lippman's autobiographical note "Chaos theory and a career in medicine" as recommended reading for medical professionals.
Clinical Expertise in Breast Cancer
Dr. Marc Lippman, MD, brings exceptional clinical expertise to breast cancer hormone therapy. His career combines rigorous endocrinology science with practical applications for improving breast cancer treatment outcomes. This dual focus has positioned Dr. Lippman as a leading authority in the field.
Dr. Lippman's approach to breast cancer treatment integrates the latest research findings with clinical practice. His work has helped shape modern endocrine therapy protocols for breast cancer patients. The interview with Dr. Anton Titov, MD, provides valuable insights into Dr. Lippman's perspectives on advancing breast cancer care through hormonal treatments.
Full Transcript
Dr. Anton Titov, MD: Hello from New York! We are with Dr. Marc Lippman, an eminent expert on the endocrine treatment of breast cancer. We will discuss hormonal treatment of breast cancer.
Dr. Marc Lippman is a Professor of Oncology and Medicine at Georgetown University in Washington, DC. Professor Lippman is a pioneer in the endocrine treatment of breast cancer. He holds board certifications in endocrinology and metabolism and medical oncology.
Dr. Marc Lippman obtained his MD from Yale University and did a residency in medicine at Johns Hopkins University and a fellowship in endocrinology at Yale University and at NIH.
Dr. Lippman's interest in the rigorous science of endocrinology, coupled with his practical interest in improving breast cancer treatment, has set him on a remarkable path of discovery and many distinguished leadership academic positions.
Dr. Lippman was Head of the Medical Breast Cancer Section at the NIH, Professor and Chair of Internal Medicine at the University of Michigan, Professor of Medicine and Chair of Medicine Department at the University of Miami, and Deputy Director of the Sylvester Comprehensive Cancer Center at the University of Miami. He was also a Professor of Medicine and Pharmacology and Chair, Department of Oncology, at Georgetown University in Washington.
Professor Marc Lippman published over 400 articles in peer-reviewed medical journals in oncology and has received numerous national and international awards for his works on endocrine aspects of breast cancer. I also strongly recommend reading Dr. Lippman's autobiographical note called "Chaos theory and a career in medicine," which you can find online.
Dr. Anton Titov, MD: Professor Lippman, hello and welcome!